Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases

Molecular Biology of the Cell

Volumn 25, Issue 3, 2014, Pages 324-336

  Wille, Christoph ^a   Köhler, Conny ^b   Armacki, Milena ^a   Jamali, Arsia ^b   Gössele, Ulrike ^a   Pfizenmaier, Klaus ^c   Seufferlein, Thomas ^a   Eiseler, Tim ^a  

^a UNIVERSITY OF ULM   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GREEN FLUORESCENT PROTEIN; MARIMASTAT; MATRILYSIN; PROTEIN KINASE D; PROTEIN KINASE D1; PROTEIN KINASE D2; UNCLASSIFIED DRUG; VASCULOTROPIN A; YELLOW FLUORESCENT PROTEIN;

ANGIOGENESIS; ARTICLE; BIOAVAILABILITY; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CHORIOALLANTOIS; ENZYME PHOSPHORYLATION; ENZYME RELEASE; EXTRACELLULAR MATRIX; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SECRETORY VESICLE; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHORIOALLANTOIC MEMBRANE; EXTRACELLULAR MATRIX; HEK293 CELLS; HELA CELLS; HUMANS; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PROTEIN KINASE C; PROTEIN KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893454194     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-06-0334     Document Type: Article

References (43)

1. Armacki M, Joodi G, Nimmagadda SC, de Kimpe L, Pusapati GV, Vandoninck S, Van Lint J, Illing A, Seufferlein T (2013). A novel splice variant of calcium and integrin-binding protein 1 mediates protein kinase D2-stimulated tumour growth by regulating angiogenesis. Oncogene, doi:10.1038/onc.2013.43.
2. Azoitei N et al. (2010). Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours. Gut 59, 1316-1330.
3. Beil M, Leser J, Lutz M P, Gukovskaya A, Seufferlein T, Lynch G, Pandol SJ, Adler G (2002). Caspase 8-mediated cleavage of plectin precedes F-actin breakdown in acinar cells during pancreatitis. Am J Physiol Gastrointest Liver Physiol 282, G450-G460.
4. Bergers G, Benjamin LE (2003). Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3, 401-410.
5. Bergers G et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2, 737-744.
6. Biswas MH, Du C, Zhang C, Straubhaar J, Languino LR, Balaji KC (2010). Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer. Cancer Res 70, 2095-2104.
7. Crawford HC, Scoggins CR, Washington MK, Matrisian LM, Leach SD (2002). Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 109, 1437-1444.
8. del Castillo C F, Warshaw L (1993). Peritoneal metastases in pancreatic carcinoma. Hepatogastroenterology 40, 430-432.
9. Doppler H, Bastea LI, Eiseler T, Storz P (2013). Neuregulin mediates F-actindriven cell migration through inhibition of protein kinase D1 via Rac1 protein. J Biol Chem 288, 455-465.
10. Dozier S, Escobar G P, Lindsey ML (2006). Matrix metalloproteinase (MMP)-7 activates MMP-8 but not MMP-13. Med Chem 2, 523-526.
11. Egeblad M, Werb Z (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2, 161-174.
12. Eiseler T, Doppler H, Yan IK, Goodison S, Storz P (2009a). Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res 11, R13.
13. Eiseler T, Doppler H, Yan IK, Kitatani K, Mizuno K, Storz P (2009b). Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot. Nat Cell Biol 11, 545-556.
14. Eiseler T, Hausser A, De Kimpe L, Van Lint J, Pfizenmaier K (2010a). Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin. J Biol Chem 285, 18672-18683.
15. Eiseler T, Hausser A, De Kimpe L, Van Lint J, Pfizenmaier K (2010b). Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin. J Bio Chem 285, 2418672-18683.
16. Eiseler T, Kohler C, Nimmagadda SC, Jamali A, Funk N, Joodi G, Storz P, Seufferlein T (2012). Protein kinase D1 mediates anchorage-dependent and -independent growth of tumor cells via the zinc finger transcription factor Snail1. J Biol Chem 287, 32367-32380.
17. Eiseler T, Schmid MA, Topbas F, Pfizenmaier K, Hausser A (2007). PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration. FEBS Lett 581, 4279-4287.
18. Guha S, Tanasanvimon S, Sinnett-Smith J, Rozengurt E (2010). Role of protein kinase D signaling in pancreatic cancer. Biochem Pharmacol 80, 1946-1954.
19. Harikumar KB et al. (2010). A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther 9, 1136-1146.
20. Hausser A, Link G, Bamberg L, Burzlaff A, Lutz S, Pfizenmaier K, Johannes FJ (2002). Structural requirements for localization and activation of protein kinase C mu (PKC mu) at the Golgi compartment. J Cell Biol 156, 65-74.
21. Hausser A, Storz P, Martens S, Link G, Toker A, Pfizenmaier K (2005). Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex. Nat Cell Biol 7, 880-886.
22. Kessenbrock K, Plaks V, Werb Z (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
23. Kleiner DE, Stetler-Stevenson WG (1994). Quantitative zymography: detection of picogram quantities of gelatinases. Analyt Biochem 218, 325-329.
24. Korc M (2003). Pathways for aberrant angiogenesis in pancreatic cancer. Mol Cancer 2, 8.
25. La Valle CR, Zhang L, Xu S, Eiseman JL, Wang QJ (2012). Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer. Mol Cancer Ther 11, 1389-1399.
26. Masson V et al. (2005). Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 19, 234-236.
27. Maupin KA et al. (2010). Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems. PloS One 5, e13002.
28. Merikallio H, Turpeenniemi-Hujanen T, Paakko P, Makitaro R, Riitta K, Salo S, Salo T, Harju T, Soini Y (2012). Snail promotes an invasive phenotype in lung carcinoma. Respir Res 13, 104.
29. Noel AC, Lefebvre O, Maquoi E, Van Hoorde L, Chenard M P, Mareel M, Foidart JM, Basset P, Rio MC (1996). Stromelysin-3 expression promotes tumor take in nude mice. J Clin Invest 97, 1924-1930.
30. Page-McCaw A, Ewald AJ, Werb Z (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8, 221-233.
31. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, Petersen G, Lou Z, Wang L (2009). FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16, 259-266.
32. Peterburs P, Heering J, Link G, Pfizenmaier K, Olayioye MA, Hausser A (2009). Protein kinase D regulates cell migration by direct phosphorylation of the cofilin phosphatase slingshot 1 like. Cancer Res 69, 5634-5638.
33. Porzner M, Seufferlein T (2011). Novel approaches to target pancreatic cancer. Curr Cancer Drug Targets 11, 698-713.
34. Pusapati GV, Krndija D, Armacki M, von Wichert G, von Blume J, Malhotra V, Adler G, Seufferlein T (2010). Role of the second cysteine-rich domain and Pro275 in protein kinase D2 interaction with ADP-ribosylation factor 1, trans-Golgi network recruitment, and protein transport. Mol Biol Cell 21, 1011-1022.
35. Rasmussen HS, McCann PP (1997). Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther 75, 69-75.
36. Rykx A, De Kimpe L, Mikhalap S, Vantus T, Seufferlein T, Vandenheede JR, Van Lint J (2003). Protein kinase D: a family affair. FEBS Lett 546, 81-86.
37. Seufferlein T (2002). Novel protein kinases in pancreatic cell growth and cancer. Int J Gastrointest Cancer 31, 15-21.
38. Snoek-van Beurden PA, Von den Hoff JW (2005). Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Bio-Techniques 38, 73-83.
39. Tsuzuki Y, Mouta Carreira C, Bockhorn M, Xu L, Jain RK, Fukumura D (2001). Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab Invest 81, 1439-1451.
40. Wang FQ, So J, Reierstad S, Fishman DA (2005). Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 114, 19-31.
41. Werb Z (1997). ECM and cell surface proteolysis: regulating cellular ecology. Cell 91, 439-442.
42. Yeaman C et al. (2004). Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. Nat Cell Biol 6, 106-112.
43. Yoo J, Rodriguez Perez CE, Nie W, Sinnett-Smith J, Rozengurt E (2011). Protein kinase D1 mediates synergistic MMP-3 expression induced by TNF-alpha and bradykinin in human colonic myofibroblasts. Biochem Biophys Res Commun 413, 30-35.